1. Albrecht M, Oremek G, Gaußmann A (1989a) Value of CA 15–3, CEA and MCA in cytosol and serum in breast carcinoma patients. In: Klapdor R (ed) Recent results in tumor diagnosis and therapy. Zuckschwerdt, München, p 120
2. Albrecht M, Reuter S, Oremek G, Gaußmann A (1989b) CEA, CA 15–3 and CA 50 im sera and tumor tissue in patients with breast cancer. In: Klapdor E (ed) Recent results in tumor diagnosis and therapy. Zuckschwerdt, München, p 72
3. Ammon A (1989) Die klinische Bedeutung der Tumormarker. Gynecologica 13: 128 – 133
4. Ammon A, Eiffert H, Weber MH, Rummel J, Niemann J (1988) Tumormarker bei dialysepflichtiger Niereninsuffizienz. Onkologie 11: 260 – 262
5. Aurelian L, Davis HJ, Julian CG (1973) Herpes-virus type 2 induced tumor-specific antigen in cervical carcinoma. Am J Epidemiol 98: 1